English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/59668
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Cancer as a reprogramming-like disease: Implications in tumor development and treatment

AuthorsCastellanos-Martín, Andrés CSIC ORCID; Vicente-Dueñas, Carolina CSIC ORCID; Campos-Sánchez, Elena CSIC ORCID ; Lazo, Pedro A. CSIC ORCID ; Pérez-Losada, J. CSIC ORCID ; Sánchez García, Isidro CSIC ORCID
Issue Date2010
CitationSeminars in Cancer Biology 20(2): 93-97 (2010)
AbstractCancer is a clonal malignant disease originated in a single cell and characterized by the accumulation of partially differentiated cells that are phenotypically reminiscent of normal stages of differentiation. Given the fact that human cancer is diagnosed at later stages and cannot be monitored during its natural evolution, the origin of tumors has been a subject of continuing discussion. Animal models provide a means to determine the identity of the cell-of-origin leading to malignancy and to develop new treatments. Recent findings in mice have shown that cancer stem cells could arise through a reprogramming-like mechanism, suggesting that genetic lesions that initiate the cancer process might be dispensable for tumor progression and maintenance. This review addresses the impact of these results toward a better understanding of carcinogenesis and proposes research avenues for tackling these issues in the future. © 2010 Elsevier Ltd.
Identifiersdoi: 10.1016/j.semcancer.2010.02.001
issn: 1044-579X
Appears in Collections:(IBMCC) Artículos
(CBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.